We have noted the ‘rolling speculations’ aspect of the broad commodities sector. At times it seems as though the hot money is rolling in and out of different commodities (ref. the general Agriculture moonshot at the end of June and big drop in early July to retrace a majority of it). Suddenly REE became all the rage and did a vertical leap after being ignored … Continue reading NFTRH+; A Commodity in a Constructive Bottom Stance
After a brief back and forth with Mark at IKN last week and a quick look at the IKN Weekly’s opening I’d like to make a disclosure on something. While there is probably no one actually wondering about it integrity is Thing 1 to me, and upon reading Mark’s opening I’d say it warrants a few words. Mark popped me an email last week inquiring … Continue reading A Disclosure
68 pages. I am going to the track for a run so I can get this stuff out of my head. Subscribe to NFTRH Premium for your 40-55 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep up to date with plenty of public content at NFTRH.com and Biiwii.com. Also, … Continue reading NFTRH 458 Out Now
You could say GILD replaced ABBV after I took its profit and now ABBV is back after I took GILD’s profit. It may sound slick, but it is really just late stage bull market trading; reaping here, planting there and managing risk and limiting losses everywhere. ABBV pulled back, almost as if on command after it hit our 1st target of 75. The SMA 50 … Continue reading ABBV Replacing GILD
A look at the general Healthcare ETF (XLV), which includes BioPharma, Devices/Equipment and Services shows it easing below the trend line. IHI is at lateral support and the SMA 50 and IBB is at a short-term trend line. XLV is probably due for a test of the SMA 50 so that is no great shakes at the moment. I don’t like that IHI ticked a … Continue reading Healthcare Charts Updated
A couple of charts from the weekly Market Internals segment of NFTRH, bearing in mind that interest rates are going to have a say about sector relative strength going forward (for example, Financials and Energy tend to do relatively well in a rising long-term rate environment while Healthcare does not). Financials are constructive, Energy is firm for a few days now (nominal XLE may be … Continue reading US Sectors vs. SPY & Some Yield Discussion
Since this is a spot on the internet that is not trying to harvest your eyeballs (no ads, man), misrepresent itself as a guru service or otherwise present uneven views of the writer’s strengths and faults, I feel the need to also present my screw ups and/or items currently not working, after putting up posts like the GILD profit-take. In that post I noted 2 … Continue reading CRY Me No Tears
It’s been a great run off the June bottom and now all Biotech profits are booked. I’ll hold general Healthcare for now, with all individual stocks in the books (except for 2 Device companies). Subscribe to NFTRH Premium for your 40-55 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep … Continue reading GILD Bye
It has been a contrarian trade that has not yet worked out; by that I mean my short position on the Euro and preparation for a firming US dollar. Yesterday the market cheered the supposedly dovish Fed, and USD got smeared again as the world’s counter party paper boosted assets far and wide… on nothing but perceptions and a hell of a lot of momentum … Continue reading Make Way For Uncle Buck
A few items jumping out at me, post-Fed. HUI is moving to its next resistance parameter, which is the declining SMA 200. That was a very valid bounce target. If it gets through there the 3 obstacles left for a new bull trend would be the June, April and February highs. The weekly sees Huey at the key resistance of the EMA 55 and a … Continue reading Post-FOMC; Gold Stocks, Gold and USD
Look, I have been beating the drum about the gold sector being in a daily downtrend until it can clear certain technical objectives. As a sector, it has not yet cleared most of them. I’ve also noted positives in play ranging from the vastly improved gold and silver CoT data to the out performance and positive divergence by several gold stocks including Royal Gold, Franco … Continue reading There’s Gold in Them There [Gold Stock] Earnings
I am hoping WEED.TO gets high(er) from here. I let my preferred Pot stock, APH.TO, get out of the barn but then looked at this one a couple days ago and saw what may have been a less mature bottom and bounce situation. So I took a shot. It got cut in half into the June low and now has climbed back above the SMA … Continue reading Wanna Get High, Man?
Last week we noted XLE’s attempt to break above the SMA 50. In NFTRH 457 we noted its unsurprising failure. Today I want to look closer, starting with the daily chart of XLE. Last week’s attempt failed and today we have a new attempt at the downtrend channel line as XLE breaks above the SMA 50 (oil is bouncing as well). To me, that is … Continue reading NFTRH; Energy and Interest Rates
After reading the Macro Tourist and finding out I am not the only guy on the planet short the Euro I got the idea to reproduce NFTRH’s Currency segment publicly. Contrarian views using public sentiment and Commitments of Traders have been great for calling the Treasury bond market over the last year but so far in expecting the USD to bottom, firm and bounce… no … Continue reading NFTRH 457 Excerpt; Currencies
